Journal of Medicinal Chemistry · 2020 · 18 citations · 46 references
PharmacyOncologyPharmacologyChemotherapyDrug DiscoveryMolecular PharmacologyCentral Nervous System Tumor PharmacotherapyHit-to-lead OptimizationLead Compound DesignLead DiscoveryTargeted Cancer TherapyTyrosine Kinase InhibitorsAlk InhibitionBlood-brain Barrier PermeabilityGlioma ChemotherapyKinase Inhibitor Library DesignOrthotopic Tumor ModelsPyridine ChemistryTargeted Inhibitor Design
pharmacokinetic (PK) properties and tolerability mark these inhibitors as advanced preclinical compounds suitable for further development and evaluation in orthotopic models of DIPG.
46
<i>Phaser</i>crystallographic software
Airlie J. McCoy, Ralf W. Grosse‐Kunstleve, Paul D. Adams et al. · Journal of Applied Crystallography · 2007 · 20.9K citations · Full text
Overview of the<i>CCP</i>4 suite and current developments
Martyn Winn, Charles Ballard, Kevin Cowtan et al. · Acta Crystallographica Section D Biological Crystallography · 2011 · 12.6K citations · Full text